Award
National Cancer Institute 5R01CA262556-03
Expanding the cancer paralog genetic interaction map to enable precision oncology
Recipient
Fred Hutchinson Cancer Center
Award Amount
$530,439.00
Ceiling
$530,439.00
Awarded
February 26, 2026
Identifier
5R01CA262556-03
This NIH grant funds research to develop synthetic lethality-based therapies targeting paralog genes in lung cancer to overcome drug resistance and improve patient survival.
Description
Develop a new therapeutic approach based on synthetic lethality to suppress cancer growth and drug resistance, focusing on lung cancer and paralog genetic interactions.